Azulfidine is the brand name for the anti-inflammatory drug sulfasalazine. It belongs to the class of aminosalicylates that are used to treat ulcerative colitis and crohn's disease. The medication is administered orally and works primarily in the gastrointestinal tract. Once absorbed it is broken down into two active components one of which exerts antimicrobial activity. The other component reduces inflammation by interfering with the production of inflammatory mediators. It modulates the immune response by inhibiting the synthesis of prostaglandins and leukotrienes. The anti-inflammatory effect helps to alleviate diarrhea bleeding and abdominal pain associated with disease flares. Pharmacologically the drug also has a sulfur moiety that contributes to its antimicrobial properties and overall therapeutic profile.

Azulfidine is the trade name for sulfapyridine, an oral medication used in the treatment of mild to moderate ulcerative colitis. Classified as a sulfonamide derivative, it belongs to the broader group of disease-modifying antirheumatic drugs but is primarily prescribed for inflammatory bowel conditions. The drug acts by delivering the active metabolite sulfapyridine, which interferes with bacterial folate synthesis and modulates intestinal immune responses. By reducing inflammation in the colon, it helps alleviate symptoms such as diarrhea, abdominal pain, and rectal bleeding associated with the disease. The mechanism involves absorption in the small intestine, conversion by intestinal flora to an active form that inhibits pyrimidine synthesis in rapidly dividing immune cells, thereby decreasing inflammatory cytokine production. Notably, its selective activation in the gut allows systemic effects to be localized to the colon, contributing to its therapeutic benefit.

Azulfidine is prescribed for ulcerative colitis and can cause nausea and loss of appetite. Some users experience headaches and dizziness during the first weeks of treatment. Mild skin reactions such as rash or itching are occasionally reported. Blood cell counts may fall leading to anemia or low white cell levels. Liver enzyme levels can rise modestly in a minority of patients. Eye irritation or blurred vision has been noted with higher doses. Prolonged use may result in folate deficiency that sometimes requires nutritional support. Most side effects improve when the medication is discontinued.

Azulfidine may cause nausea or loss of appetite in some users. Headache and mild dizziness are also reported occasionally. Skin reactions such as rash or itching can occur. Photosensitivity to sunlight is a known side effect. Some patients experience temporary changes in blood cell counts. Elevated liver enzymes have been observed in infrequent cases. Blood test abnormalities may appear in a small percentage of patients.